Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122358) titled 'Application of Tiglidine in Hysteroscopic Surgery and Its Impact on Perioperative Complications' on April 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Guangzhou Women and Children Medical Center Liuzhou Hospital
Condition:
Intrauterine diseases
Intervention:
Group T1:Propofol at 2 mg/kg was administered for sedation. In the up-and-down sequential trial, the initial dose of tiglidine for the first patient was 10 µg/kg, with adjacent doses increased or decreased by 2 µg/kg. Subsequent doses were determined based on the response of the previous patient. A positive re...